FDA Inspection 1079838 — Carter BloodCare at Keller

Carter BloodCare at Keller — FEI 3003706080

The FDA completed an inspection of Carter BloodCare at Keller on January 24, 2019 in Keller, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 24, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Keller, TX (United States)